Answers are grounded in this paper and cite their sources.
Review outlines diagnostic approaches and treatments for congenital athymia, indicating cultured thymus tissue as a key therapy distinct from SCID management.
), similar to a phenotype of severe combined immunodeficiency (SCID); these patients may require additional steps to confirm the diagnosis if no known genetic cause of athymia is identified. However, distinguishing athymia from SCID is crucial, as treatments differ for these conditions. Cultured thymus tissue is being investigated as a treatment for congenital athymia. Here, we review what is known about the epidemiology, underlying etiologies, clinical manifestations, and treatments for congenital athymia.
No takes yet. Share an insight, caveat, or question.
Collins et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: